PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,436,245 | -35.2% | 138,500 | -10.5% | 0.00% | – |
| Q2 2023 | $2,214,846 | +537.2% | 154,668 | +217.7% | 0.00% | – |
| Q1 2023 | $347,583 | -58.1% | 48,681 | -34.2% | 0.00% | – |
| Q4 2022 | $830,414 | +30.8% | 74,012 | +29.1% | 0.00% | – |
| Q3 2022 | $635,000 | +43.7% | 57,342 | +9.5% | 0.00% | – |
| Q2 2022 | $442,000 | +14.5% | 52,372 | +84.8% | 0.00% | – |
| Q1 2022 | $386,000 | -42.5% | 28,337 | -16.9% | 0.00% | – |
| Q4 2021 | $671,000 | +191.7% | 34,117 | +376.3% | 0.00% | – |
| Q3 2021 | $230,000 | -84.3% | 7,163 | -83.7% | 0.00% | – |
| Q4 2020 | $1,464,000 | +624.8% | 44,078 | +579.0% | 0.00% | – |
| Q4 2019 | $202,000 | – | 6,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 4,901,358 | $41,368,000 | 8.59% |
| Frazier Life Sciences Management, L.P. | 5,827,415 | $49,183,000 | 4.64% |
| Abingworth LLP | 1,435,106 | $12,112,000 | 3.88% |
| Penn Mutual Asset Management | 86,940 | $734,000 | 0.99% |
| 683 Capital Management, LLC | 1,440,000 | $12,153,000 | 0.86% |
| Western Standard LLC | 109,055 | $920,000 | 0.70% |
| MPM BioImpact LLC | 193,326 | $1,632,000 | 0.45% |
| Newtyn Management, LLC | 255,767 | $2,159,000 | 0.41% |
| StepStone Group LP | 422,085 | $3,562,000 | 0.38% |
| Avidity Partners Management LP | 1,919,800 | $16,203,000 | 0.37% |